Senior-living with resort-like amenities coming to East Memphis

By Sophia Surret – Daily Memphian

January 21, 2024

The Avaline at River Oaks will be a 114-unit assisted-living and memory-care facility developed by Avaline at River Oaks LLC, a partnership between Twin Bridges Investments and VH Development, Harrison Young and Edgar McKee.

The developers are refurbishing a 73,000-square-foot building on a 2.85-acre lot previously occupied by the senior community Laurel Glen. The purchase price was $4.6 million.

“We’re doing a major remodel of it,” Young said. “We’re gutting it, all the finishes. Everything will be new within the building but structurally the same building.”

Young said buying an existing building lowers costs and allows for a more budget-conscious rental rate.

When completed this summer, the facility will have 90 assisted-living and 24 memory-care apartments managed by Claiborne Senior Living.

Assisted-living units will include studios and one-bedroom apartments with kitchenettes. Studios will start at $4,190 per month (257–357 square feet), and one-bedroom units will start at $4,840 (343–357 square feet).

Memory-care apartments, all studios, will range from 208 to 374 square feet and start at $5,540 per month. These units include additional care, services, and a more secure environment.

The memory-care units will also include monitoring technology designed to help staff respond to and potentially predict health events such as falls.

The community is intended for residents aged 55 and older who need assistance with daily activities or benefit from increased socialization and support.

Amenities will include on-site physical therapy, a movie theater, game room, creative space, courtyards, transportation, a bistro and bar, salon and barbershop, library nook, and outdoor dining space.

“All services are included, and they don’t have to go anywhere,” Dunne said.

Previous
Previous

Simmons Bank stadium renovation to start in May

Next
Next

Memphis facility to make gene-editing treatment for sickle cell